1. Home
  2. TBLA vs ABCL Comparison

TBLA vs ABCL Comparison

Compare TBLA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$4.16

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
ABCL
Founded
2007
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
TBLA
ABCL
Price
$4.16
$4.11
Analyst Decision
Strong Buy
Buy
Analyst Count
6
5
Target Price
$4.80
$7.75
AVG Volume (30 Days)
1.3M
4.8M
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$1,880,771,000.00
$35,325,000.00
Revenue This Year
$11.31
$25.45
Revenue Next Year
$5.75
$10.07
P/E Ratio
$53.27
N/A
Revenue Growth
10.96
7.17
52 Week Low
$2.50
$1.89
52 Week High
$4.65
$6.52

Technical Indicators

Market Signals
Indicator
TBLA
ABCL
Relative Strength Index (RSI) 48.64 52.05
Support Level $4.02 $3.92
Resistance Level $4.35 $4.85
Average True Range (ATR) 0.10 0.34
MACD -0.03 0.02
Stochastic Oscillator 37.18 49.95

Price Performance

Historical Comparison
TBLA
ABCL

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: